BlackRock’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-259,600
| Closed | -$56.3M | – | 5637 |
|
|
2021
Q1 | $56.3M | Sell |
259,600
-7,925
| -3% | -$1.49M | ﹤0.01% | 2542 |
|
|
2020
Q4 | $30.9M | Sell |
267,525
-23,129
| -8% | -$2.59M | ﹤0.01% | 2774 |
|
|
2020
Q3 | $28.3M | Sell |
290,654
-198,916
| -41% | -$22.9M | ﹤0.01% | 2665 |
|
|
2020
Q2 | $60.1M | Buy |
489,570
+66,139
| +16% | +$7.5M | ﹤0.01% | 2140 |
|
|
2020
Q1 | $37.1M | Buy |
423,431
+151,692
| +56% | +$16.1M | ﹤0.01% | 2252 |
|
|
2019
Q4 | $28.4M | Sell |
271,739
-19,754
| -7% | -$2.22M | ﹤0.01% | 2683 |
|
|
2019
Q3 | $33.5M | Sell |
291,493
-174,807
| -37% | -$26.5M | ﹤0.01% | 2525 |
|
|
2019
Q2 | $80.4M | Sell |
466,300
-63,924
| -12% | -$11.1M | ﹤0.01% | 2045 |
|
|
2019
Q1 | $89.4M | Sell |
530,224
-18,771
| -3% | -$2.79M | ﹤0.01% | 1938 |
|
|
2018
Q4 | $53.5M | Sell |
548,995
-19,792
| -3% | -$2.6M | ﹤0.01% | 2199 |
|
|
2018
Q3 | $98.3M | Sell |
568,787
-78,141
| -12% | -$11.3M | ﹤0.01% | 1982 |
|
|
2018
Q2 | $90.3M | Sell |
646,928
-127,105
| -16% | -$18.1M | ﹤0.01% | 2014 |
|
|
2018
Q1 | $87.2M | Sell |
774,033
-475
| -0.1% | -$59.7K | ﹤0.01% | 1944 |
|
|
2017
Q4 | $102M | Sell |
774,508
-56,000
| -7% | -$6.58M | ﹤0.01% | 1866 |
|
|
2017
Q3 | $84.3M | Buy |
830,508
+327,290
| +65% | +$35.1M | ﹤0.01% | 1942 |
|
|
2017
Q2 | $50.4M | Buy |
503,218
+185,317
| +58% | +$19.9M | ﹤0.01% | 2251 |
|
|
2017
Q1 | $38.4M | Buy |
317,901
+317,876
| +1,271,504% | +$39M | ﹤0.01% | 2385 |
|
|
2016
Q4 | $3K | Hold |
25
| – | – | ﹤0.01% | 3618 |
|
|
2016
Q3 | $3K | Hold |
25
| – | – | ﹤0.01% | 3585 |
|
|
2016
Q2 | $2K | Hold |
25
| – | – | ﹤0.01% | 3659 |
|
|
2016
Q1 | $2K | Hold |
25
| – | – | ﹤0.01% | 3481 |
|
|
2015
Q4 | $2K | Buy |
+25
| New | +$2.04K | ﹤0.01% | 3345 |
|
Other funds holding GWPH
BlackRock's GWPH Position: Q2 2021 in Review
BlackRock sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 259,600 shares — an estimated $56.3M sold.
BlackRock first reported a position in GWPH in Q4 2015 and held it in 22 quarters. The position peaked at $102M in Q4 2017. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- BlackRock reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- BlackRock sold 259,600 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $56.3M.
- BlackRock first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2015 and held it in 22 quarters.
- BlackRock's GW Pharmaceuticals Plc American Depositary Shares position peaked at $102M in Q4 2017.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.